SCHEDULE: Alta Partners Reports Stake in BioRestorative Therapies

Alta Partners LLC has filed a Schedule 13G, reporting beneficial ownership of 4.99% of BioRestorative Therapies, Inc. common stock.

Summary

• Alta Partners LLC has filed an amendment to its Schedule 13G, indicating a change in its beneficial ownership of BioRestorative Therapies, Inc. common stock.
• The filing reports that Alta Partners LLC beneficially owns 1,338,133 shares of BioRestorative Therapies, Inc. common stock.
• This ownership represents 4.99% of the class of securities.
• The reporting person has sole voting power and sole dispositive power over these shares.
• The filing is an amendment, suggesting a prior filing or a change in the ownership percentage.
• The date of the event requiring this filing is February 13, 2026.

Sentiment

Score: 3

Explanation: StockSavvy.ai views this filing as neutral to slightly negative, as it primarily reports a change in ownership stake below a significant threshold, without new strategic or financial information.

Positives

• Alta Partners LLC maintains a significant, though below 5%, ownership stake, indicating continued interest in BioRestorative Therapies, Inc.

Negatives

• The filing does not provide any new strategic initiatives, financial performance updates, or positive developments for BioRestorative Therapies, Inc.

Risks

• The filing does not explicitly mention any new risks or challenges for BioRestorative Therapies, Inc.

Future Outlook

No forward-looking statements or guidance are provided in this filing.

Management Comments

• Steven Cohen, Managing Member of Alta Partners LLC, certified that the securities were not acquired or held for the purpose of influencing control of the issuer.

Industry Context

StockSavvy.ai notes that Schedule 13G filings typically report passive ownership stakes by institutional investors. This filing indicates Alta Partners LLC's position as a significant, but not controlling, shareholder in the biotechnology sector.

Stakeholder Impact

• Shareholders may note Alta Partners LLC's continued significant stake, which could influence market perception but does not indicate a change in control.

Key Dates

Keywords

BioRestorative Therapies, Alta Partners LLC, Schedule 13G, Beneficial Ownership, Common Stock, Ownership Stake